Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2019-11-04 Regulatory Filings
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2019
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related transactions for the month ended 31/10/2019. The content focuses on share capital changes, share issuance, and confirmations related to securities issued. There are no financial statements, earnings data, or management discussion of financial results. The document is a regulatory filing reporting monthly share capital movements and related confirmations to the stock exchange, consistent with a regulatory compliance announcement rather than a financial report or capital raising update. Therefore, it fits best under Regulatory Filings (RNS).
2019-11-04 English
VOLUNTARY ANNOUNCEMENT - IN RELATION TO A STRATEGIC COOPERATION FRAMEWORK AGREEMENT WITH BEIJING CAI-YAN TECHNOLOGY CO., LTD.
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Sinopharm Tech Holdings Limited regarding a strategic cooperation framework agreement with another company. It details the nature of the cooperation, the scope, benefits, and background information about the companies involved. There are no financial statements, regulatory certifications, voting results, or management changes reported. The document is an announcement of a business development event rather than a financial report or regulatory filing. It is not a report publication announcement since it does not mention any report being published or attached. The content fits best under a general regulatory announcement category that informs shareholders and investors about significant business developments but does not fall into more specific categories like M&A, capital updates, or earnings releases. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2019-11-03 English
DATE OF BOARD MEETING
Board/Management Information Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding the date of a board meeting scheduled for November 13, 2019. The purpose of the meeting includes approving the unaudited consolidated results for the three months ended September 30, 2019, and considering dividend payment. The document is short (2372 characters) and serves as a notice of an upcoming board meeting rather than containing any financial data or detailed report. It does not contain actual financial statements or substantive analysis, nor does it present the results themselves. It is not a full quarterly or interim report, nor an earnings release. The document is an announcement related to management activities (board meeting scheduling and agenda). Therefore, the most appropriate classification is Board/Management Information (MANG).
2019-11-01 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 95% confidence The document is titled 'NOTICE OF ANNUAL GENERAL MEETING' and contains detailed information about the upcoming AGM of Sinopharm Tech Holdings Limited, including the date, location, agenda items such as receiving audited financial statements, re-election of directors, re-appointment of auditors, and resolutions related to share allotment and repurchase authorities. It is a formal announcement inviting shareholders to attend the AGM and vote on various resolutions. The document does not contain the actual financial statements or reports but rather the notice and agenda for the meeting. Therefore, it is not the Annual Report (10-K) or any other report but a notice related to the AGM. This fits the category AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including notices of meetings and agendas.
2019-10-21 English
FORM OF PROXY
AGM Information Classification · 95% confidence The document is a Form of Proxy for use by shareholders at the Annual General Meeting (AGM) of Sinopharm Tech Holdings Limited. It includes instructions for appointing a proxy to vote on resolutions at the AGM, such as receiving the audited financial statements, re-electing directors, appointing auditors, and granting mandates related to shares. The document is procedural and related to the AGM meeting process rather than the actual AGM materials or presentations. It does not contain financial statements or detailed report content but is a proxy voting form for the AGM. Therefore, it fits best under AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including proxy forms and related documents.
2019-10-21 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a circular from Sinopharm Tech Holdings Limited dated 22 October 2019, containing detailed information about proposals for general mandates to issue and repurchase shares, re-election of retiring directors, and notice of the Annual General Meeting (AGM). It includes a letter from the board, explanatory statements, details of directors proposed for re-election, and the notice of the AGM itself. The document is clearly intended to inform shareholders about the AGM agenda and related resolutions. It is not a report of the AGM results, nor is it a financial report or earnings release. The presence of the notice of AGM and proxy form enclosed with the circular aligns with the typical content of AGM Information filings. Therefore, the document fits the category of AGM Information (AGM-R). The document length (15,000 characters) and detailed content confirm it is the actual circular, not just an announcement of a report publication or a brief notice.
2019-10-21 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.